Tianjin Chase Sun Pharmaceutical Co.,Ltd (300026.SZ)
CNY 4.11
(0.0%)
CNY 4.11
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.53 Billion | 745.34 Million | 391.59 Million | 196.66 Million | 216.1 Million | 388.19 Million |
| Net Income | 506.63 Million | 620.97 Million | 670.85 Million | 559.67 Million | 408.43 Million | 215.91 Million |
| Depreciation & Amortization | 346.1 Million | 306.79 Million | 261.46 Million | 189.98 Million | 156.17 Million | 131.39 Million |
| Deferred income taxes | -768.06 Thousand | -3.09 Million | 6.05 Million | -29.37 Million | -20.11 Million | -16.74 Million |
| Stock-based compensation | - | - | 3.94 Million | 17.91 Million | 23.84 Million | - |
| Change in working capital | 483.72 Million | -363.34 Million | -831.09 Million | -796.91 Million | -548.35 Million | -318.12 Million |
| Other non-cash items | 193.64 Million | 180.92 Million | 290.37 Million | 243.9 Million | 199.84 Million | 359.02 Million |
| Investing Cash Flow | -402.67 Million | -728.44 Million | -642.27 Million | -562.04 Million | -504.95 Million | -309.78 Million |
| Investments in PPE | -347.12 Million | -770.27 Million | -677.45 Million | -563.78 Million | -591.01 Million | -294.89 Million |
| Acquisitions | 2.13 Million | 223.83 Thousand | 205.71 Thousand | -3.39 Million | 4.55 Million | -15.63 Million |
| Investment purchases | -3.12 Million | -9.05 Million | -10.12 Million | -13.03 Million | -162.01 Million | -132.65 Million |
| Sales/Maturities of investments | 11.78 Thousand | 45.54 Million | 27.15 Million | 37.45 Million | 242.49 Million | 133.05 Million |
| Other Investing Activities | -54.57 Million | 5.11 Million | 17.94 Million | -19.28 Million | 1.02 Million | 345.56 Thousand |
| Financing Cash Flow | -767.89 Million | -150.59 Million | 464.79 Million | 500.31 Million | 167.09 Million | -218.42 Million |
| Debt repayment | -546.4 Million | -745.23 Million | -916.29 Million | -535.35 Million | -320.5 Million | -272.39 Million |
| Dividends payments | -90.12 Million | -120.16 Million | -120.16 Million | -150.28 Million | -59.52 Million | -70.9 Million |
| Common Stock Repurchased | - | - | - | -2.54 Million | -16.2 Million | -101.9 Million |
| Common Stock Issuance | - | - | - | 2.54 Million | 16.2 Million | - |
| Other Financing Activities | -66.79 Million | 785.41 Million | 1.53 Billion | 1.21 Billion | 557.73 Million | 124.86 Million |
| Accounts receivables | 690.83 Million | 172.97 Million | -1.04 Billion | -845.37 Million | -646.26 Million | -156.7 Million |
| Accounts payables | -430.08 Million | 380.85 Million | 97.09 Million | 615.76 Million | 395.84 Million | -40.18 Million |
| Inventory | 223.74 Million | -914.08 Million | 106.35 Million | -537.93 Million | -277.81 Million | -104.48 Million |
| Other working capital | -768.06 Thousand | -3.09 Million | 6.05 Million | -29.37 Million | -20.11 Million | -213.64 Million |
| Cash at beginning of period | 1.2 Billion | 1.29 Billion | 1.08 Billion | 968.98 Million | 1.08 Billion | 1.22 Billion |
| Cash at end of period | 1.54 Billion | 1.18 Billion | 1.29 Billion | 1.08 Billion | 968.98 Million | 1.08 Billion |
| Capital Expenditure | -347.12 Million | -770.27 Million | -677.45 Million | -563.78 Million | -591.01 Million | -294.89 Million |
| Effect of forex changes on cash | 5.48 Million | 22.91 Million | -6.26 Million | -17.65 Million | 2.07 Million | 4.13 Million |
| Net cash flow / Change in cash | 341.27 Million | -110.78 Million | 207.85 Million | 117.27 Million | -119.68 Million | -135.88 Million |
| Free Cash Flow | 1.18 Billion | -24.92 Million | -285.85 Million | -367.11 Million | -374.91 Million | 93.3 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 20.12 Million | 90.11 Million | 58.12 Million | -2.55 Million | 506.63 Million | 163.3 Million |
| Depreciation & Amortization | - | 93.55 Million | 93.55 Million | 92.85 Million | 346.1 Million | 92.85 Million |
| Deferred income taxes | - | - | - | - | -768.06 Thousand | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | 920.08 Million | 483.72 Million | -117.57 Million |
| Other non-cash items | 130.26 Million | 220.55 Million | 79.5 Million | -472.88 Million | 193.64 Million | 385.73 Million |
| Investing Cash Flow | -79.88 Million | -31.72 Million | -48.57 Million | -247.67 Million | -402.67 Million | -42.57 Million |
| Investments in PPE | -30.09 Million | -31.74 Million | -48.57 Million | -194.7 Million | -347.12 Million | -39.65 Million |
| Acquisitions | 177.32 Thousand | 25.35 Thousand | 1740.00 | 1.6 Million | 2.13 Million | 204.76 Thousand |
| Investment purchases | -50 Million | - | - | - | -3.12 Million | -3.12 Million |
| Sales/Maturities of investments | 28.47 Thousand | - | - | - | 11.78 Thousand | 2.92 Million |
| Other Investing Activities | -49.79 Million | 25.35 Thousand | 1740.00 | -54.57 Million | -54.57 Million | -2.92 Million |
| Financing Cash Flow | -664.58 Million | -148.5 Million | -37.02 Million | -287.03 Million | -767.89 Million | -86.43 Million |
| Debt repayment | -615.65 Million | -42.12 Million | -14.81 Million | -280.15 Million | -546.4 Million | -84.37 Million |
| Dividends payments | -28.44 Million | -93 Million | -7.76 Million | -90.12 Million | -90.12 Million | -32.34 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -20.48 Million | -78.56 Million | -22.2 Million | 2.45 Million | -66.79 Million | 30.27 Million |
| Accounts receivables | - | - | - | 690.83 Million | 690.83 Million | -179.41 Million |
| Accounts payables | - | - | - | - | -430.08 Million | - |
| Inventory | - | - | - | 223.74 Million | 223.74 Million | 59.87 Million |
| Other working capital | - | - | - | 5.5 Million | -768.06 Thousand | 1.96 Million |
| Cash at beginning of period | 1.63 Billion | 1.61 Billion | 1.57 Billion | 1.56 Billion | 1.2 Billion | 1.15 Billion |
| Cash at end of period | 1.04 Billion | 1.64 Billion | 1.61 Billion | 1.54 Billion | 1.54 Billion | 1.54 Billion |
| Capital Expenditure | -30.09 Million | -31.74 Million | -48.57 Million | -194.7 Million | -347.12 Million | -39.65 Million |
| Effect of forex changes on cash | -1.31 Million | 1.61 Million | -186.21 Thousand | -1.73 Million | 5.48 Million | -1.09 Million |
| Net cash flow / Change in cash | -595.4 Million | 31.07 Million | 43.85 Million | -19.74 Million | 341.27 Million | 394.22 Million |
| Free Cash Flow | 120.29 Million | 185.36 Million | 89.04 Million | 342.8 Million | 1.18 Billion | 484.67 Million |
300011
0188
NDA
SUPR
BLDE
CODI-PA